Michael D. McGoon

Active 1982–2019

85
Papers
38,603
Citations
81
h-index
85
i10-index

Citations

Citations per year for Michael D. McGoon1960: 6 citations1979: 1 citations1982: 1 citations1984: 1 citations1985: 8 citations1986: 7 citations1987: 16 citations1988: 11 citations1989: 15 citations1990: 12 citations1991: 16 citations1992: 20 citations1993: 16 citations1994: 17 citations1995: 23 citations1996: 32 citations1997: 56 citations1998: 82 citations1999: 127 citations2000: 108 citations2001: 93 citations2002: 134 citations2003: 134 citations2004: 184 citations2005: 164 citations2006: 202 citations2007: 191 citations2008: 254 citations2009: 294 citations2010: 302 citations2011: 275 citations2012: 366 citations2013: 458 citations2014: 334 citations2015: 303 citations2016: 279 citations2017: 201 citations2018: 220 citations2019: 767 citations2020: 739 citations2021: 593 citations2022: 521 citations2023: 275 citations2024: 470 citations2025: 199 citations2026: 7 citations1961–1978: no citations, so these years are not shown1980–1981: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,668 citing papers, 30.7% of this breakdownUnited Kingdom: 736 citing papers, 8.5% of this breakdownGermany: 571 citing papers, 6.6% of this breakdownFrance: 502 citing papers, 5.8% of this breakdownItaly: 455 citing papers, 5.2% of this breakdownCanada: 428 citing papers, 4.9% of this breakdownChina: 380 citing papers, 4.4% of this breakdownNetherlands: 336 citing papers, 3.9% of this breakdownJapan: 246 citing papers, 2.8% of this breakdownSwitzerland: 227 citing papers, 2.6% of this breakdownAustralia: 198 citing papers, 2.3% of this breakdownBelgium: 194 citing papers, 2.2% of this breakdown
0%30.7%Other 20.1%

Fields

  • Medicine91.5%
  • Biochemistry, Genetics and Molecular Biology3.6%
  • Neuroscience1.2%
  • Engineering0.9%
  • Health Professions0.5%
  • Immunology and Microbiology0.4%
  • Other1.9%

Topics

  • Pulmonary Hypertension Research and Treatments20.8%
  • Cardiovascular Function and Risk Factors6.7%
  • Cardiac Valve Diseases and Treatments3.7%
  • Congenital Heart Disease Studies3.5%
  • Heart Failure Treatment and Management3.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.9%
  • Other59.3%

Coauthors

All papers

Open in search
  1. Predicting Survival in Patients With Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , - CHEST Journal 2019 cited by 631

  2. Predicting Survival in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Circulation 2010 cited by 1,550

  3. Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , - CHEST Journal 2009 cited by 1,180

  4. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

    Authors: , , , , , - CHEST Journal 2012 cited by 1,107

  5. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , - Circulation 2008 cited by 1,080

  6. Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

    Authors: , , , , , , , , , , - CHEST Journal 2015 cited by 520

  7. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 1996 cited by 2,695

  8. Valvular Heart Disease Associated with Fenfluramine–Phentermine

    Authors: , , , , , , - New England Journal of Medicine 1997 cited by 1,635

  9. Right Ventricular Function and Failure

    Authors: , , , , , , , , , , , , , - Circulation 2006 cited by 1,250

  10. REVEAL: a contemporary US pulmonary arterial hypertension registry

    Authors: , - European Respiratory Review 2012 cited by 267

  11. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Authors: , , , , , , , , , , , , - Circulation 2009 cited by 2,355

  12. Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 519

  13. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

    Authors: , , , , , , , - CHEST Journal 2011 cited by 557

  14. Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

    Authors: , , , , , , , , - CHEST Journal 2010 cited by 432

  15. Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management

    Authors: , , , , , - CHEST Journal 2011 cited by 206

  16. The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

    Authors: , , , , , , , , , , , , - CHEST Journal 2010 cited by 351

  17. Relationship of Pulmonary Arterial Capacitance and Mortality in Idiopathic Pulmonary Arterial Hypertension

    Authors: , , , , - Journal of the American College of Cardiology 2006 cited by 411

  18. Portopulmonary Hypertension

    Authors: , , , , , , - CHEST Journal 2011 cited by 296

  19. Delay in Recognition of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - CHEST Journal 2011 cited by 292

  20. Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension

    Authors: , , , , - CHEST Journal 2013 cited by 166

  21. Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2000 cited by 1,075

  22. Echocardiographically Documented Mitral-Valve Prolapse

    Authors: , , , , , - New England Journal of Medicine 1985 cited by 586

  23. The importance of patient perspectives in pulmonary hypertension

    Authors: , , , , , , , , - European Respiratory Journal 2018 cited by 122

  24. Right Ventricular Strain for Prediction of Survival in Patients With Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - CHEST Journal 2010 cited by 344